Candela's ALEXlazr cleared by FDA:
This article was originally published in Clinica
Executive Summary
Candela's ALEXlazr has been cleared by the US FDA for treating pigmented skin lesions. Such lesions are commonly caused by sun exposure and sun damage. The device had previously been cleared for removing tattoos and pigmented dermal lesions. The treatment costs between $100 and $400 per session. The company based in Wayland, Massachusetts, estimates the potential worldwide market to be $2,000 million with over 28 million people in the US alone requiring the treatment.